Published in Lancet Infect Dis on September 04, 2012
Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis. Lancet Glob Health (2015) 1.86
The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study. PLoS Med (2015) 1.71
Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014. PLoS Negl Trop Dis (2016) 1.39
Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med (2013) 1.29
Cholera vaccination in urban Haiti. Am J Trop Med Hyg (2013) 1.21
Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ (2014) 1.19
Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator. Am J Trop Med Hyg (2014) 0.86
Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. PLoS One (2014) 0.82
Killed oral cholera vaccines: history, development and implementation challenges. Ther Adv Vaccines (2014) 0.81
Development of a cholera vaccination policy on the Island of Hispaniola, 2010-2013. Am J Trop Med Hyg (2013) 0.80
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Clin Vaccine Immunol (2014) 0.79
The case for a typhoid vaccine probe study and overview of design elements. Vaccine (2015) 0.78
Infection: mass vaccination is feasible in response to cholera epidemics. Nat Rev Gastroenterol Hepatol (2013) 0.78
Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines. Hum Vaccin Immunother (2014) 0.77
A case for control of cholera in Africa by vaccination. Lancet Infect Dis (2012) 0.76
Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan. Sci Rep (2016) 0.75
Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach. BMC Public Health (2016) 0.75
Questioning the Effectiveness of Oral Cholera Vaccine in Port-au-Prince Slums. Am J Trop Med Hyg (2016) 0.75
Epidemiology of cholera in the Philippines. PLoS Negl Trop Dis (2015) 0.75
Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016. Vaccine (2017) 0.75
A prolonged, community-wide cholera outbreak associated with drinking water contaminated by sewage in Kasese District, western Uganda. BMC Public Health (2017) 0.75
Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2017) 0.75
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol (2010) 6.28
The international Ebola emergency. N Engl J Med (2014) 5.35
The global burden of cholera. Bull World Health Organ (2012) 5.03
A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med (2009) 4.84
Programme costs in the economic evaluation of health interventions. Cost Eff Resour Alloc (2003) 4.64
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med (2006) 4.19
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet (2005) 4.16
A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ (2008) 4.11
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet (2009) 3.97
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med (2005) 3.68
Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities. AIDS (2009) 2.89
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis (2013) 2.82
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis (2011) 2.79
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother (2007) 2.73
Cost effectiveness analysis of strategies for child health in developing countries. BMJ (2005) 2.71
Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis (2012) 2.58
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med (2016) 2.50
Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine (2006) 2.49
Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med (2014) 2.39
The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis (2008) 2.36
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Controlling endemic cholera with oral vaccines. PLoS Med (2007) 2.21
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008. J Clin Microbiol (2009) 2.16
The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. BMC Infect Dis (2005) 2.10
Health economics of dengue: a systematic literature review and expert panel's assessment. Am J Trop Med Hyg (2011) 2.05
Helicobacter in the developing world. Microbes Infect (2003) 2.02
Salmonella paratyphi A rates, Asia. Emerg Infect Dis (2005) 1.94
Trend and disease burden of bacillary dysentery in China (1991-2000). Bull World Health Organ (2006) 1.93
The future of dengue vaccines. Lancet (2002) 1.90
Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis (2011) 1.89
Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ (2008) 1.86
Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.84
Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement. PLoS Med (2012) 1.82
Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies. PLoS One (2010) 1.81
Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis (2011) 1.73
A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One (2010) 1.72
Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value Health (2009) 1.72
The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis (2011) 1.70
Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J (2008) 1.69
Ebola vaccine--an urgent international priority. N Engl J Med (2014) 1.66
Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J (2012) 1.61
Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett (2004) 1.59
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One (2008) 1.57
High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children. J Clin Microbiol (2003) 1.55
Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa. Bull World Health Organ (2011) 1.54
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother (2010) 1.54
Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population. BMC Infect Dis (2006) 1.53
Factors associated with reported diarrhoea episodes and treatment-seeking in an urban slum of Kolkata, India. J Health Popul Nutr (2004) 1.53
Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis (2009) 1.53
Evaluation of a rapid immunochromatographic dipstick kit for diagnosis of cholera emphasizes its outbreak utility. Jpn J Infect Dis (2010) 1.52
Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine (2005) 1.50
Local environmental predictors of cholera in Bangladesh and Vietnam. Am J Trop Med Hyg (2008) 1.50
Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis (2012) 1.49
Integration of Spatial and Social Network Analysis in Disease Transmission Studies. Ann Assoc Am Geogr (2012) 1.48
Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt. J Clin Microbiol (2004) 1.46
Pandemic serovars (O3:K6 and O4:K68) of Vibrio parahaemolyticus associated with diarrhea in Mozambique: spread of the pandemic into the African continent. J Clin Microbiol (2005) 1.46
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. Eur Respir J (2012) 1.45
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother (2009) 1.45
Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ (2005) 1.45
Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage. J Med Microbiol (2006) 1.44
Reducing stunting among children: the potential contribution of diagnostics. Nature (2006) 1.44
Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine (2011) 1.44